Literature DB >> 1660075

Hyaluronidase levels in urine from Wilms' tumor patients.

M Stern1, M T Longaker, N S Adzick, M R Harrison, R Stern.   

Abstract

The pathophysiology of Wilms' tumor is associated with major alterations in hyaluronic acid metabolism. Elevated levels of both hyaluronic acid and a hyaluronic acid-stimulating activity occur in the urine and serum of patients with this tumor. In the current study, we describe elevated levels of urinary hyaluronidase in five patients with Wilms' tumor. Following surgical removal of the tumor, enzyme levels decreased toward normal. Characterization of enzyme activity indicates that hyaluronidase may be produced by the tumor itself. Alternatively, normal renal tissue may also be producing enzyme in a compensatory response to the elevated hyaluronic acid levels in these patients. We suggest that urinary hyaluronidase can be used as an additional marker for Wilms' tumor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660075     DOI: 10.1093/jnci/83.21.1569

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

Review 1.  Wilms' tumor.

Authors:  R P Warrier; O Regueira
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

2.  Urinary hyaluronidase activity in rats infected with Blastocystis hominis--evidence for invasion?

Authors:  S Chandramathi; Kumar Govind Suresh; A A Mahmood; U R Kuppusamy
Journal:  Parasitol Res       Date:  2010-04-01       Impact factor: 2.289

3.  Effect of hyaluronidase on the pharmacokinetics of free and total platinum species after intra-arterial Cisplatin in refractory patients with colorectal liver metastases.

Authors:  D Civalleri; M Esposito; F De Cain; F Decian; N Balletto; G Mondini; L Gogioso; M Viale; M O Vannozzi
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

4.  Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma.

Authors:  T Spruss; G Bernhardt; H Schönenberger; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 5.  Hyalurondiase: both a tumor promoter and suppressor.

Authors:  Vinata B Lokeshwar; Marie G Selzer
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 6.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

7.  Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.

Authors:  K Beckenlehner; S Bannke; T Spruss; G Bernhardt; H Schönenberg; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.

Authors:  Michael V Ortiz; Saima Ahmed; Melissa Burns; Anton G Henssen; Travis J Hollmann; Ian MacArthur; Shehana Gunasekera; Lyvia Gaewsky; Gary Bradwin; Jeremy Ryan; Anthony Letai; Ying He; Arlene Naranjo; Yueh-Yun Chi; Michael LaQuaglia; Todd Heaton; Paolo Cifani; Jeffrey S Dome; Samantha Gadd; Elizabeth Perlman; Elizabeth Mullen; Hanno Steen; Alex Kentsis
Journal:  JCI Insight       Date:  2019-08-08

9.  Therapeutic targeting of hyaluronan in the tumor stroma.

Authors:  Anne Kultti; Xiaoming Li; Ping Jiang; Curtis B Thompson; Gregory I Frost; H Michael Shepard
Journal:  Cancers (Basel)       Date:  2012-09-06       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.